共 17 条
[1]
Topotecan and small cell lung cancer. Schiller JH. Lung Cancer . 2000
[2]
Novel approaches in the treatment of NSCLC. Rosell R. Lung Cancer . 2000
[3]
The new generation of chemotherapy agents in the treatment of elderly. Manegold C. Lung Cancer . 2000
[4]
Combination of gemcitabine and carboplatin as first line treatment in non-small cell lung cancer. Carrato A,Alberola V,Massuti B,et al. Annals of Oncology . 1998
[5]
Management of relapsed small cell lung cancer. Postmus PE,Smit EF. Lung Cancer . 2000
[6]
New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future direction. Bunn PA Jr,Kelly K. Clinical Cancer Research . 1998
[7]
Topotecan, a new active drug in the secondline treatment of small cell lung cancer: a phaseⅡstudy in patients with refractory and sensitive disease. Ardizzoni A,Hansen H,Dombernowsky P,et al. Journal of Clinical Oncology . 1997
[8]
Management of limited stage small cell lung cancer—2000. Curran WJ. Lung Cancer . 2000
[9]
Paclitaxel and carboplatin in the treatment of small cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a noncross-resistant schedule. Groen HJ,Fokkema E,Biesma B,et al. Journal of Clinical Oncology . 1999
[10]
Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small cell lung cancer: Comparison of sequential phase Ⅱtrials using different dose-intensities. Hainsworth JD,Gray JR,Stroup SL,et al. Journal of Clinical Oncology . 1997